Pharmanest, Inc
Clinical trials sponsored by Pharmanest, Inc, explained in plain language.
-
AI-Powered liver test could spot hidden risks in fatty liver patients
Diagnosis CompletedThis study looked at over 1,200 adults with metabolic fatty liver disease (MASLD) to see if a new digital test, called FibroNest Ph-FCS, can predict who will develop serious liver complications. The test uses computer analysis of standard liver biopsy images to measure scarring. …
Sponsor: PharmaNest, Inc • Aim: Diagnosis
Last updated Jun 27, 2026 12:00 UTC
-
Digital biopsy score may predict liver failure risk in fatty liver patients
Knowledge-focused CompletedThis study looked at whether a computer analysis of liver biopsy images (called FibroNest Ph-FCS) can predict future liver complications in people with a type of fatty liver disease called MASLD. Researchers reviewed medical records from 1,578 patients to see if the digital score…
Sponsor: PharmaNest, Inc • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:00 UTC